Literature DB >> 26081040

Alteration of CD4 T cell subsets in metastatic lymph nodes of human gastric cancer.

Yoshihiro Okita1, Masaichi Ohira1, Hiroaki Tanaka1, Mao Tokumoto1, Yukie Go1, Katsunobu Sakurai1, Takahiro Toyokawa1, Naoshi Kubo1, Kazuya Muguruma1, Tetsuji Sawada1, Kiyoshi Maeda1, Kosei Hirakawa1.   

Abstract

Studies of tumor-infiltrating immune cells have revealed that immune escape plays an important role in tumor growth. The aim of the present study was to investigate the impact of metastasis affecting CD4+ T cell subsets in human clinical samples. Single-cell suspensions derived from tumor-draining lymph node (TDLN) and primary cancer specimens were assessed by flow cytometry, qRT-PCR and immunohistochemistry. In the CD4+ T cell subsets detected in TDLN, effector T cells (TE) in metastatic TDLN (mTDLN) was significantly lower than that in metastatic-free TDLN (mfTDLN). TE in mfTDLN were increased compared with normal controls. Similarly, effector memory T cells (TEM) in mTDLN was significantly lower than in control and mfTDLN. There was a significantly positive correlation between the proportion of TEM in TDLN and number of tumor-infiltrating CD4+ and CD8+ T cells. Th1 to Th2 ratio was lower in mTDLN, and Treg in mTDLN was significantly higher than in mfTDLN. CD4+ T cell and TE subsets in TDLN were significantly affected by metastasis. Immunosuppressive cells exhibit increased migration to TDLN, in which a subset of CD4+ TE is skewed towards immune tolerance in the tumor microenvironment.

Entities:  

Mesh:

Year:  2015        PMID: 26081040     DOI: 10.3892/or.2015.4064

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  m7G Methylation-Related Genes as Biomarkers for Predicting Overall Survival Outcomes for Hepatocellular Carcinoma.

Authors:  Xin-Yu Li; Zhi-Jie Zhao; Jing-Bing Wang; Yu-Hao Shao; Jian-Xiong You; Xi-Tao Yang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-10

Review 2.  Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer.

Authors:  Hui-Ying Ma; Xin-Zhou Liu; Chun-Min Liang
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

3.  Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.

Authors:  Chuang Zhang; Danni Li; Ruoxi Yu; Ce Li; Yujia Song; Xi Chen; Yibo Fan; Yunpeng Liu; Xiujuan Qu
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

4.  Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.

Authors:  Renate Pichler; Georg Gruenbacher; Zoran Culig; Andrea Brunner; Dietmar Fuchs; Josef Fritz; Hubert Gander; Andrea Rahm; Martin Thurnher
Journal:  Cancer Immunol Immunother       Date:  2016-12-22       Impact factor: 6.968

5.  Notch signaling pathway regulates CD4+CD25+CD127dim/- regulatory T cells and T helper 17 cells function in gastric cancer patients.

Authors:  Lu Yang; Ke-Lei Zhao; Lei Qin; Dan-Xia Ji; Bin Zhang; Peng-Fei Zheng; Yong-Mei Qin
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.